Endurance RP (RPGLF) Price & Analysis

Compare

10 Followers

RPGLF Stock Chart & Stats

$0.12

$0.06(150.00%)

At close: Dec 24 4:00 PM EST

$0.12

$0.06(150.00%)

Day’s Range― - ―

52-Week Range$0.10 - $0.43

Previous CloseN/A

Volume1.00K

Average Volume (3M)0.00

Market Cap

$33.58M

Enterprise Value$35.20M

Total Cash (Recent Filing)$147.00K

Total Debt (Recent Filing)$1.77M

Price to Earnings (P/E)―

Beta-4.09

Next Earnings

Mar 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding291,815,800

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.03

Price to Book (P/B)-1.82

Price to Sales (P/S)14.92

P/FCF Ratio-2.59

Enterprise Value/Market Cap1.05

Enterprise Value/Revenue38.56

Enterprise Value/Gross Profit298.33

Enterprise Value/Ebitda1.90

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained, high double‑digit revenue growth demonstrates accelerating demand and market traction. A growing top line provides room to scale fixed costs, improve unit economics, and fund strategic initiatives, forming a durable basis for eventual margin recovery if maintained.

Operational Profitability (EBITDA)A 25.05% EBITDA margin indicates the core business generates substantial operating cash before non‑cash and financing items. This reflects efficient cost structure and product economics, offering a structural lever for converting top‑line growth into sustainable profits if financing and non‑operating losses are managed.

Free Cash Flow ImprovementPositive FCF growth and FCF covering net income show improving cash conversion, a durable sign of strengthening internal funding capacity. Over months this can reduce dependence on external capital, support debt reduction or reinvestment, and improve financial flexibility if the trend continues.

Bears Say

Negative Equity / Balance Sheet RiskNegative stockholders' equity reflects accumulated deficits that erode the capital base and increase insolvency risk. This structural weakness constrains borrowing, investor confidence, and strategic options, and may force recapitalization or restructuring within a multi‑month horizon if not remedied.

Negative Operating Cash FlowPersistent negative operating cash flow means core operations still consume cash despite FCF gains. This is unsustainable long term and implies reliance on financing or non‑recurring items; it raises liquidity and execution risk and undermines the business's ability to self‑fund growth or cover obligations.

Ongoing Net LossesAn ongoing net loss and negative margin show the company has not yet converted revenue growth into bottom‑line profitability. Continued losses deplete reserves, limit reinvestment capacity, and increase the need for external capital or cost restructuring, pressuring long‑term viability without corrective action.

Endurance RP News

Regent Pacific Sets Out Enhanced Audit Committee Mandate and Structure

An update from Endurance RP ( ($HK:0575) ) is now available. Regent Pacific Group Limited has formalised and...

3M ago

Deep Longevity Expands into U.S. Market with Strategic Leadership Appointments

Endurance RP ( ($HK:0575) ) has issued an announcement. Deep Longevity has announced key leadership appointments as part...

3M ago

Deep Longevity Announces Strategic U.S. Market Entry in 2026

Endurance RP ( ($HK:0575) ) has shared an update. Deep Longevity, a leader in AI-driven aging clocks and...

3M ago

Endurance RP Reports Reduced Loss and Progress in Key Markets

An announcement from Endurance RP ( ($HK:0575) ) is now available. Endurance RP has reported a reduced loss...

6M ago

Regent Pacific Schedules Board Meeting for Interim Results

The latest update is out from Endurance RP ( ($HK:0575) ). Regent Pacific Group Limited, a company listed...

7M ago

Endurance RP Advances in China and Longevity Markets

An update from Endurance RP ( ($HK:0575) ) is now available. Endurance RP announced significant progress in its...

8M ago

Regent Pacific Group Limited Announces Board Composition and Committee Roles

Endurance RP ( ($HK:0575) ) just unveiled an announcement. Regent Pacific Group Limited has announced the composition of...

8M ago

Regent Pacific Group Forms Nomination Committee to Enhance Governance

An announcement from Endurance RP ( ($HK:0575) ) is now available. Regent Pacific Group Limited, incorporated in the...

8M ago

Regent Pacific Group Limited Announces Changes to Nomination Committee

Endurance RP ( ($HK:0575) ) just unveiled an update. Regent Pacific Group Limited, a company with a diverse...

8M ago

Regent Pacific Completes Loan Capitalisation with New Share Issuance

The latest announcement is out from Endurance RP ( ($HK:0575) ). Regent Pacific Group Limited has completed a...

8M ago

RPGLF FAQ

What was Endurance RP’s price range in the past 12 months?

Endurance RP lowest stock price was $0.10 and its highest was $0.43 in the past 12 months.

What is Endurance RP’s market cap?

Endurance RP’s market cap is $33.58M.

When is Endurance RP’s upcoming earnings report date?

Endurance RP’s upcoming earnings report date is Mar 31, 2026 which is in 24 days.

How were Endurance RP’s earnings last quarter?

Endurance RP released its earnings results on Aug 27, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.

Is Endurance RP overvalued?

According to Wall Street analysts Endurance RP’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Endurance RP pay dividends?

Endurance RP pays a Notavailable dividend of $26 which represents an annual dividend yield of N/A. See more information on Endurance RP dividends here

What is Endurance RP’s EPS estimate?

Endurance RP’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Endurance RP have?

Endurance RP has 291,815,800 shares outstanding.

What happened to Endurance RP’s price movement after its last earnings report?

Endurance RP reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Endurance RP?

Currently, no hedge funds are holding shares in RPGLF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Endurance RP

Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.